BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28687463)

  • 21. Non-astmatic Eosinophilic Bronchitis.
    Yıldız T; Dülger S
    Turk Thorac J; 2018 Jan; 19(1):41-45. PubMed ID: 29404185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic cough: eosinophilic bronchitis without asthma.
    Gibson PG; Dolovich J; Denburg J; Ramsdale EH; Hargreave FE
    Lancet; 1989 Jun; 1(8651):1346-8. PubMed ID: 2567371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice.
    D'silva L; Hassan N; Wang HY; Kjarsgaard M; Efthimiadis A; Hargreave FE; Nair P
    Can Respir J; 2011; 18(3):144-8. PubMed ID: 21766077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophilic bronchitis: clinical manifestations and implications for treatment.
    Gibson PG; Fujimura M; Niimi A
    Thorax; 2002 Feb; 57(2):178-82. PubMed ID: 11828051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls.
    Zhan C; Xu R; Li B; Liu J; Liang W; Zhang S; Fang L; Zhong S; de Silva SDSH; Sivapalan D; Luo W; Li J; Lai K; Zhong N; Sehmi R; O'Byrne PM; Chen R
    Front Immunol; 2022; 13():737968. PubMed ID: 35432356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of chronic airway obstruction in patients with eosinophilic bronchitis: a prospective follow-up study.
    Park SW; Lee YM; Jang AS; Lee JH; Hwangbo Y; Kim DJ; Park CS
    Chest; 2004 Jun; 125(6):1998-2004. PubMed ID: 15189914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of eosinophilic bronchitis.
    Joo JH; Park SJ; Park SW; Lee JH; Kim DJ; Uh ST; Kim YH; Park CS
    Korean J Intern Med; 2002 Mar; 17(1):31-7. PubMed ID: 12014210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The mechanism of airway inflammation in eosinophilic bronchitis and cough variant asthma].
    Wang JL; Ren ZY; Xia JB; Huang S; Qi MH; Wang LM; Ye J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):433-7. PubMed ID: 21781515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough.
    Oh MJ; Lee JY; Lee BJ; Choi DC
    Chest; 2008 Nov; 134(5):990-995. PubMed ID: 18583518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophilic bronchitis: clinical features, management and pathogenesis.
    Birring SS; Berry M; Brightling CE; Pavord ID
    Am J Respir Med; 2003; 2(2):169-73. PubMed ID: 14720015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eotaxin and IL-4 levels are increased in induced sputum and correlate with sputum eosinophils in patients with nonasthmatic eosinophilic bronchitis.
    Zhang R; Luo W; Liang Z; Tan Y; Chen R; Lu W; Zhong N
    Medicine (Baltimore); 2017 Mar; 96(13):e6492. PubMed ID: 28353595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cough. 4: Cough in asthma and eosinophilic bronchitis.
    Dicpinigaitis PV
    Thorax; 2004 Jan; 59(1):71-2. PubMed ID: 14694253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of treatment with inhaled corticosteroids in nonasthmatic eosinophilic bronchitis: a randomized open label trial.
    Zhan W; Tang J; Chen X; Yi F; Han L; Liu B; Luo W; Chen Q; Lai K
    Ther Adv Respir Dis; 2019; 13():1753466619891520. PubMed ID: 31847717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eosinophilic airway disorders.
    Scott KA; Wardlaw AJ
    Semin Respir Crit Care Med; 2006 Apr; 27(2):128-33. PubMed ID: 16612763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
    Brightling CE; Ward R; Woltmann G; Bradding P; Sheller JR; Dworski R; Pavord ID
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):878-82. PubMed ID: 10988099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Circulating CD4
    Huang J; Liu J; Xian Y; Liu B; Wu Y; Zhan C; Liang W; Luo W; Lai K; Chen R
    Lung; 2020 Jun; 198(3):491-497. PubMed ID: 32367413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eosinophilic bronchitis in the workplace.
    Quirce S
    Curr Opin Allergy Clin Immunol; 2004 Apr; 4(2):87-91. PubMed ID: 15021059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PGE(2) decreases muscle cell proliferation in patients with non-asthmatic eosinophilic bronchitis.
    Sastre B; Fernández-Nieto M; López E; Gámez C; Aguado E; Quirce S; del Pozo V; Sastre J
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):11-8. PubMed ID: 21458581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
    Brightling CE; Symon FA; Birring SS; Bradding P; Wardlaw AJ; Pavord ID
    Thorax; 2003 Jun; 58(6):528-32. PubMed ID: 12775868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of impulse oscillometry and fractional exhaled nitric oxide in children with Eosinophilic bronchitis.
    Kim YH; Kim KW; Baek J; Park HB; Kim H; Song KJ; Lee JM; Sohn MH; Kim KE
    Pediatr Pulmonol; 2013 Mar; 48(3):221-8. PubMed ID: 22825832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.